Bioclinic Naturals Somno-Pro®, 90 Enteric Coated Softgels
$32.99
In stock
SKU
bioclinic-naturals-somno-pro%c2%ae-90-enteric-coated-softgel
Benefits
- Addresses every facet of insomnia: difficulty initiating sleep, difficulty maintaining sleep, waking too early in the morning, and waking groggy
- Reduces nervous system excitation, which can inhibit sleep
- Contains Suntheanine®, the most clinically studied L-theanine
- Enteric coated
Feature Summary
L-Theanine, 5-hydroxytryptophan (5-HTP) and melatonin have all been shown to independently improve sleep quality and quantity, and/or lessen anxiety. L-Theanine is an amino acid found almost exclusively in tea,1 which influences the central nervous system through a number of mechanisms, primarily by influencing levels of the neurotransmitters dopamine,2 gamma-aminobutyric acid (GABA),3,4 serotonin,5,6 norepinephrine6 and glutamate.7,8 These effects cause a significant increase in alpha brain wave activity, indicative of a state of wakeful relaxation, increased performance under stress, improved learning and concentration, as well as decreased anxiety.1,9 5-HTP is the intermediary between L-tryptophan and serotonin, a key neurotransmitter associated with sleep, mood, and anxiety.10-12 5-HTP bypasses the rate limiting enzyme tryptophan hydroxylase, which normally limits the conversion of tryptophan to serotonin.13 Melatonin is also closely related, and is formed by conversion of serotonin in the pineal gland. Known to regulate many biological rhythms, including the circadian cycle, melatonin has shown clinical benefit for inducing sleep or adjusting sleep cycles.14 Randomized trials have found it to reduce sleep onset latency and improve perceived quality of sleep, without impairing daytime psychomotor performance.15,16Medicinal Ingredients
| Each Softgel Contains: | |
| Suntheanine® L-Theanine | 100 mg |
| 5-Hydroxy-L-Tryptophan (L-5-HTP) (Griffonia simplicifolia) (seed) | 15 mg |
| Melatonin | 1.5 mg |
Non-Medicinal Ingredients
Softgel (gelatin, glycerin, purified water), organic flaxseed oil, yellow beeswax, non-GMO sunflower lecithin, enteric coating (purified water, ethylcellulose, medium chain triglycerides, oleic acid, sodium alginate, stearic acid).Dosage:
Recommended Adult Dose: 2 softgels per day 30–45 minutes prior to bedtime or as directed by a health care practitioner. Consult a health care practitioner for use beyond 4 weeks. Do not take on an empty stomach.Allergens:
Contains no artificial colours, preservatives, or sweeteners; no dairy, starch, sugar, wheat, gluten, yeast, soy, corn, egg, fish, shellfish, salt, tree nuts, or GMOs. Sealed for your protection. Do not use if seal is broken. For freshness, store in a cool, dry place.Contraindications
Discontinue use if you show signs of weakness, oral ulcers, or abdominal pain accompanied by severe muscle pain, or if you experience skin changes. Do not use if you are taking blood pressure, immunosuppressive, sedative/hypnotic medication, or if you are pregnant or breastfeeding or have scleroderma. Some people may experience drowsiness. Do not drive or operate heavy machinery for 5 hours after using this product. Exercise caution if involved in activities requiring mental alertness.Drug Interactions
L-theanine is known to have a hypotensive effect in some individuals, and concomitant use ofantihypertensive drugs may potentiate their activity.17References
1. Juneja, L.R., Chu, D.C., Okubo, T., et al. (1999). L-Theanine – a unique amino acid of green tea and its relaxation effect in humans. Trends in Food Science & Technology, 10(2), 199-204. 2. Yokogoshi, H., Kobayashi, M., Mochizuki, M., et al. (1998). Effect of theanine, r-glutamylethylamide, on brain monoamines and striatal dopamine release in conscious rats. Neurochem Res, 23(5), 667-73. 3. Kimura, R., Murata, T. (1971). Influence of alkylamides of glutamic acid and related compounds on the central nervous system. I. Central depressant effect of theanine. Chem Pharm Bull, (Tokyo), 19(6), 1257-61. 4. Alternative Medicine Review. Gamma-Aminobutyric Acid (GABA), Monograph. (2007). Altern Med Rev, 12(3), 274-9. 5. Yokogoshi, H., Mochizuki, M., Saitoh, K. (1998). Theanine-induced reduction of brain serotonin concentration in rats. Biosci Biotechnol Biochem, 62(4), 816-7. 6. Kimura, R., Murata, T. (1986). Effect of theanine on norepinephrine and serotonin levels in rat brain. Chem Pharm Bull (Tokyo), 34(7), 3053-7. 7. Kakuda T. (2002). Neuroprotective effects of green tea components theanine and catechins. Biol Pharm Bull, 25(12), 1513-8. 8. Kimura, K., Ozeki, M., Juneja, L.R., et al. (2007). L-theanine reduces psychological and physiological stress responses. Biol Psychol, 74(1), 39-45. 9. Nobre, A.C, Rao, A., Owen, G.N. (2008). L-theanine, a natural constituent in tea, and its effect on mental state. Asia Pac J Clin Nutr, 17 Suppl, 167-8. 10. Birdsall, T.C. (1998). 5-Hydroxytryptophan: a clinically effective serotonin precursor. Altern Med Rev, 3(4), 271-80. 11. Wyatt, R.J., Zarcone, V., Engelman, K., et al. Effects of 5-hydroxytryptophan on the sleep of normal human subjects. Electroencephalogr Clin Neurophysiol, 30(6), 505-9. 12. Soulairac, A., Lambinet, H. (1998). Clinical studies of the effect of the serotonin precursor, L-5-Hydroxytryptophan, on sleep disorders. Schweiz Rundsch Med Prax, 77(34A), 19-23. 13. Shaw, K., Turner, J., Del Mar, C. (2002). Tryptophan and 5-hydroxytryptophan for depression. Cochrane Database Syst Rev, (1), CD003198. 14. Kunz, D., Mahlberg, R., Muller, C., et al. (2004). Melatonin in patients with reduced REM sleep duration: two randomized controlled trials. J Clin Endocrinol Metab, 89(1), 128-34. 15. Wade, A.G., Ford, I., Crawford, G., et al. (2007). Efficacy of prolonged release melatonin in insomnia patients aged 55–80 years: quality of sleep and next day alertness outcomes. Curr Med Res Opin, 23(10), 2597-605. 16. Wade, A.G., Ford, I., Crawford, G., et al. (2010). Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety. BMC Med, 8, 51. 17. Yokogoshi, H., Kobayashi. M. (1998). Hypotensive effect of gamma-glutamylmethylamide ontaneously hypertensive rats. Life Sci, 62(12), 1065-8.You may also like:
